Analgesics - Czechia | Statista Market Forecast

In Czechia, the revenue in the Analgesics market reaches US$147.90m in 2024.
It is projected to experience an annual growth rate of 6.76% (CAGR 2024-2029).
When compared to other countries worldwide, the United States generates the highest revenue of US$7.24bn in 2024.
Looking at the per person revenues in Czechia, each individual generates US$14.08 in 2024.
The demand for over-the-counter analgesics in Czechia is increasing due to an aging population and a rise in chronic pain conditions.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Czechia has been experiencing steady growth in recent years, driven by various factors such as changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences: In Czechia, customers have shown a growing preference for over-the-counter (OTC) analgesics due to their convenience and accessibility. OTC analgesics offer a quick and easy solution for common ailments such as headaches, muscle pain, and fever. Customers appreciate the ability to purchase these medications without a prescription, saving them time and effort. Additionally, customers are increasingly seeking analgesics that provide fast and long-lasting relief, leading to a rise in demand for products with advanced formulations and extended-release mechanisms.

Trends in the market: One of the key trends in the Analgesics market in Czechia is the increasing demand for natural and herbal remedies. Customers are becoming more health-conscious and are seeking alternative solutions that have fewer side effects. This trend has led to the emergence of a wide range of herbal analgesics in the market, including products containing ingredients such as ginger, turmeric, and willow bark. Manufacturers are capitalizing on this trend by introducing new products that cater to the growing demand for natural remedies.Another trend in the market is the growing popularity of online retail channels. With the advent of e-commerce platforms, customers now have the option to conveniently purchase analgesics online. This trend has not only expanded the reach of analgesic products to customers in remote areas but has also increased price transparency and competition among retailers. Online platforms also offer customers the convenience of comparing prices and reading reviews before making a purchase, further influencing their buying decisions.

Local special circumstances: Czechia has a well-developed healthcare system, with a high level of accessibility to healthcare services. This has contributed to the growth of the Analgesics market, as customers have easy access to healthcare professionals who can recommend and prescribe analgesics when needed. Additionally, the country has a high level of public awareness about the importance of managing pain and seeking appropriate treatment, which further drives the demand for analgesics.

Underlying macroeconomic factors: Czechia has experienced steady economic growth in recent years, which has positively impacted the Analgesics market. As disposable incomes rise, customers have more purchasing power to spend on healthcare products, including analgesics. Furthermore, the aging population in Czechia is driving the demand for analgesics, as older individuals are more likely to experience chronic pain and require regular pain management.In conclusion, the Analgesics market in Czechia is developing due to changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customers are increasingly opting for OTC analgesics and natural remedies, while online retail channels are gaining popularity. The well-developed healthcare system and public awareness about pain management contribute to the growth of the market. The steady economic growth and aging population in Czechia also play a significant role in driving the demand for analgesics.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.